Behind the Scenes: Key Lessons Learned from the RELIEVE-AKI Clinical Trial

Overview

Journal J Crit Care

Specialty Critical Care

Date 2024 Jun 16

PMID 38879964

Authors

Nasrin Nikravangolsefid

Supawadee Suppadungsuk

Waryaam Singh

Paul M Palevsky

Raghavan Murugan

Kianoush B Kashani

Affiliations

Soon will be listed here.

Abstract

Continuous kidney replacement therapy (CKRT) is commonly used to manage critically ill patients with severe acute kidney injury. While recent trials focused on the correct dosing and timing of CKRT, our understanding regarding the optimum dose of net ultrafiltration is limited to retrospective data. The Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI) trial has been conducted to assess the feasibility of a prospective randomized trial in determining the optimum net ultrafiltration rate. This paper outlines the relevant challenges and solutions in implementing this complex ICU-based trial. Several difficulties were encountered, starting with clinical issues related to conducting a trial on patients with rapidly changing hemodynamics, low patient recruitment rates, increased nursing workload, and the enormous volume of data generated by patients undergoing prolonged CKRT. Following several brainstorming sessions, several points were highlighted to be considered, including the need to streamline the intervention, add more flexibility in the trial protocols, ensure comprehensive a priori planning, particularly regarding nursing roles and their compensation, and enhance data management systems. These insights are critical for guiding future ICU-based dynamically titrated intervention trials, leading to more efficient trial management, improved data quality, and enhanced patient safety.

Citing Articles

Protocolized fluid balance neutralization during continuous renal replacement therapy.

Murugan R, Prowle J, Beaubien-Souligny W Intensive Care Med. 2024; 50(12):2141-2143.

PMID: 39480517 DOI: 10.1007/s00134-024-07698-9.

References

Schjorring O, Klitgaard T, Perner A, Wetterslev J, Lange T, Siegemund M . Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure. N Engl J Med. 2021; 384(14):1301-1311. DOI: 10.1056/NEJMoa2032510. View

Parienti J, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A . Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008; 299(20):2413-22. DOI: 10.1001/jama.299.20.2413. View

Veldhoen R, Howes D, Maslove D . Is Mortality a Useful Primary End Point for Critical Care Trials?. Chest. 2019; 158(1):206-211. DOI: 10.1016/j.chest.2019.11.019. View

Bagshaw S, Wald R, Adhikari N, Bellomo R, da Costa B, Dreyfuss D . Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020; 383(3):240-251. DOI: 10.1056/NEJMoa2000741. View

Murugan R, Bellomo R, Palevsky P, Kellum J . Ultrafiltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol. 2020; 17(4):262-276. DOI: 10.1038/s41581-020-00358-3. View

Uusalo P, Hellman T, Jarvisalo M . Mortality and associated risk factors in perioperative acute kidney injury treated with continuous renal replacement therapy. Perioper Med (Lond). 2021; 10(1):57. PMC: 8670067. DOI: 10.1186/s13741-021-00227-y. View

Lamontagne F, Meade M, Hebert P, Asfar P, Lauzier F, Seely A . Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016; 42(4):542-550. DOI: 10.1007/s00134-016-4237-3. View

Burns K, Prats C, Maione M, Lanceta M, Zubrinich C, Jeffs L . The Experience of Surrogate Decision Makers on Being Approached for Consent for Patient Participation in Research. A Multicenter Study. Ann Am Thorac Soc. 2016; 14(2):238-245. DOI: 10.1513/AnnalsATS.201606-425OC. View

Murugan R, Balakumar V, Kerti S, Priyanka P, Chang C, Clermont G . Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018; 22(1):223. PMC: 6151928. DOI: 10.1186/s13054-018-2163-1. View

10.

Uchino S, Kellum J, Bellomo R, Doig G, Morimatsu H, Morgera S . Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294(7):813-8. DOI: 10.1001/jama.294.7.813. View

11.

Attia Z, Harmon D, Behr E, Friedman P . Application of artificial intelligence to the electrocardiogram. Eur Heart J. 2021; 42(46):4717-4730. PMC: 8500024. DOI: 10.1093/eurheartj/ehab649. View

12.

Rewa O, Ortiz-Soriano V, Lambert J, Kabir S, Heung M, House A . Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study. Kidney Med. 2023; 5(6):100641. PMC: 10238597. DOI: 10.1016/j.xkme.2023.100641. View

13.

Wiedemann H, Wheeler A, Bernard G, Thompson B, Hayden D, deBoisblanc B . Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24):2564-75. DOI: 10.1056/NEJMoa062200. View

14.

Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J . An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med. 2012; 40(6):1753-60. DOI: 10.1097/CCM.0b013e318246b9c6. View

15.

Silverman H, Luce J, Lanken P, Morris A, Harabin A, Oldmixon C . Recommendations for informed consent forms for critical care clinical trials. Crit Care Med. 2005; 33(4):867-82. DOI: 10.1097/01.ccm.0000159201.08203.10. View

16.

Murugan R, Ostermann M, Peng Z, Kitamura K, Fujitani S, Romagnoli S . Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners. Crit Care Med. 2020; 48(2):e87-e97. DOI: 10.1097/CCM.0000000000004092. View

17.

Naorungroj T, Serpa Neto A, Zwakman-Hessels L, Yanase F, Eastwood G, Murugan R . Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy. Nephrol Dial Transplant. 2020; 36(6):1112-1119. DOI: 10.1093/ndt/gfaa032. View

18.

Palevsky P, Zhang J, OConnor T, Chertow G, Crowley S, Choudhury D . Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359(1):7-20. PMC: 2574780. DOI: 10.1056/NEJMoa0802639. View

19.

Garcia K, Abrahao A . Research Development Using REDCap Software. Healthc Inform Res. 2021; 27(4):341-349. PMC: 8654330. DOI: 10.4258/hir.2021.27.4.341. View

20.

Kashani K, Thongprayoon C, Cheungpasitporn W, Iacovella G, Akhoundi A, Albright Jr R . Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study. PLoS One. 2017; 12(9):e0185064. PMC: 5619733. DOI: 10.1371/journal.pone.0185064. View